American Oncology Network Overview
Valuation check: AONC's P/E ratio is -17.39, below the sector sector average of 44.85.
Get informed when a big investor buys or sells
+ Follow-17.39
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
American Oncology Network's p/e ratio stands at -17.39. That is below the sector sector average of 44.85. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
American Oncology Network sits lower the its sector benchmark (44.85) with a P/E ratio of -17.39. That is roughly 138.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether -17.39 is attractive depends on American Oncology Network's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how American Oncology Network's P/E ratio evolved across reporting periods, while the comparison chart places AONC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
